Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
DXCM Insider Trading: DEXCOM INC Insider Buys and Sells · https://wallstpal.com/stock/dxcm/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

DEXCOM INC (DXCM) Insider Trading

17 open-market trades reported since Jun 17, 2026: 0 purchases worth $0 and 17 sales worth $9.22M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Michael Jon BrownGeneral Counsel0$05$699KOct 19, 2026
Sadie SternEVP0$02$448KSep 30, 2026
Nicholas AugustinosDirector0$02$680KSep 16, 2026
Jereme M. SylvainEVP0$01$303KSep 14, 2026
Kevin R. SayerExecutive Chair0$03$6.38MAug 24, 2026
Bridgette P. HellerDirector0$01$89KAug 13, 2026
Mark G. FolettaDirector0$03$627KAug 4, 2026

All trades

DXCM insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 19Oct 15Michael Jon BrownGeneral CounselGeneral Counsel▼ SELL10b5-11,70085.48$145K−1.7%Form 4 ↗
Sep 30Sep 28Sadie SternEVPEVP▼ SELL10b5-12,56586.15$221K−2.0%Form 4 ↗
Sep 16Sep 15Nicholas AugustinosDirectorDirector (ind.)▼ SELL10b5-16,53984.04$550K−18%Form 4 ↗
Sep 16Sep 15Michael Jon BrownGeneral CounselGeneral Counsel▼ SELL10b5-11,70084.04$143K−1.7%Form 4 ↗
Sep 16Sep 14Nicholas AugustinosDirectorDirector (ind.)▼ SELL10b5-11,55084.02$130K−4.1%Form 4 ↗
Sep 14Sep 10Jereme M. SylvainEVPEVP▼ SELL10b5-13,63883.27$303K−2.4%Form 4 ↗
Aug 28Aug 27Sadie SternEVPEVP▼ SELL10b5-12,56588.37$227K−2.0%Form 4 ↗
Aug 24Aug 20Kevin R. SayerExecutive ChairExecutive Chair▼ SELL10b5-126,75690.01$2.41M−8.1%Form 4 ↗
Aug 17Aug 14Michael Jon BrownGeneral CounselGeneral Counsel▼ SELL10b5-11,70091.93$156K−1.6%Form 4 ↗
Aug 13Aug 12Bridgette P. HellerDirectorDirector▼ SELL10b5-11,01288.29$89K−3.3%Form 4 ↗
Aug 4Aug 3Mark G. FolettaDirectorDirector (ind.)▼ SELL10b5-12,00085.32$171K−3.9%Form 4 ↗
Aug 4Jul 31Mark G. FolettaDirectorDirector (ind.)▼ SELL10b5-12,00080.00$160K−3.8%Form 4 ↗
Jul 21Jul 20Kevin R. SayerExecutive ChairExecutive Chair▼ SELL10b5-126,75676.32$2.04M−7.5%Form 4 ↗
Jul 16Jul 15Michael Jon BrownGeneral CounselGeneral Counsel▼ SELL10b5-11,70074.42$127K−1.6%Form 4 ↗
Jul 7Jul 6Kevin R. SayerExecutive ChairExecutive Chair▼ SELL10b5-126,75672.00$1.93M−7.0%Form 4 ↗
Jun 17Jun 15Mark G. FolettaDirectorDirector (ind.)▼ SELL10b5-14,00074.14$297K−7.0%Form 4 ↗
Jun 17Jun 15Michael Jon BrownGeneral CounselGeneral Counsel▼ SELL10b5-11,70075.55$128K−1.6%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings